heiBIB: Erben, Philipp

Erben, Philipp Dr. med.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (104)
deutsch (6)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Reike, Moritz: An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer / Moritz J. Reike, Alina Reicherz, Karl H. Tully, Henning Bahlburg, Moritz Maas, Peter Bach, Niklas Kl… , June 2024. - 7 S.
In: Urologia internationalis, ISSN 1423-0399. 108(2024), 3, Seite 183-189
DOI: 10.1159/000536321
Haas, Maximilian: Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert BC Monitor / Maximilian Haas, Maximilian C. Kriegmair, Johannes Breyer, Danijel Sikic, Felix Wezel, Florian Roghm… , November 2024. - 8 S.
In: BJU international, ISSN 1464-410X. 134(2024), 5 vom: Nov., Seite 755-762
DOI: 10.1111/bju.16389
Uysal, Daniel: Prognostic significance of EGFR, AREG and EREG amplification and gene expression in muscle invasive bladder cancer / Daniel Uysal, Blerta Thaqi, Alexander Fierek, David Jurgowski, Zoran V. Popovic, Fabian Siegel, Maur… , 28 May 2024. - 12 S. : Illustrationen
In: Frontiers in oncology, ISSN 2234-943X. 14(2024), Artikel-ID 1370303, Seite 1-12
DOI: 10.3389/fonc.2024.1370303
Cox, Alexander: Molecular urothelial tumor cell subtypes remain stable during metastatic evolution / Alexander Cox, Niklas Klümper, Johannes Stein, Danijel Sikic, Johannes Breyer, Christian Bolenz, Flo… , April 2024. - 5 S. : Illustrationen
In: European urology, ISSN 1873-7560. 85(2024), 4 vom: Apr., Seite 328-332
DOI: 10.1016/j.eururo.2023.03.020
Breyer, Johannes: Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) / Johannes Breyer, Markus Eckstein, Danijel Sikic, Felix Wezel, Florian Roghmann, Mirco Brehmer, Ralph… , 18 September 2023. - 10 S. : Illustrationen
In: Scientific reports, ISSN 2045-2322. 13(2023), Artikel-ID 15437, Seite 1-10
DOI: 10.1038/s41598-023-42088-z
Koch, Jonas: Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder / Jonas Koch, Manuel Neuberger, Martina Schmidt-Dengler, Jinyun Xu, Vitor Coutinho Carneiro, Jörg Elli… , 18 August 2023. - 17 S. : Illustrationen
In: iScience, ISSN 2589-0042. 26(2023), 8 vom: Aug., Artikel-ID 107300, Seite 1-17
DOI: 10.1016/j.isci.2023.107300
Klümper, Niklas: Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with Enfortumab vedotin resistance / Niklas Klümper, Damian J. Ralser, Jörg Ellinger, Florian Roghmann, Julia Albrecht, Eduard Below, Abd… , 15 April 2023. - 10 S.
In: Clinical cancer research, ISSN 1557-3265. 29(2023), 8 vom: Apr., Seite 1496-1505
DOI: 10.1158/1078-0432.CCR-22-1764
Neuberger, Manuel: Integrin expression in localized prostate cancer : a TCGA and MSKCC cohort-based exploratory in silico analysis / Manuel Neuberger, Lisa Frey, Katja Nitschke, Frederik Wessels, Niklas Westhoff, Frank Waldbillig, Ma… , January 2023. - 12 S.
In: Anticancer research, ISSN 1791-7530. 43(2023), 1 vom: Jan., Seite 417-428
DOI: 10.21873/anticanres.16177
Erlmeier, Franziska: Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition / Franziska Erlmeier, Niklas Klümper, Laura Landgraf, Pamela L. Strissel, Reiner Strick, Danijel Sikic… , 25 January 2023. - 10 S.
In: European urology, ISSN 1873-7560. 83(2023), 2 vom: Jan., Seite 133-142
DOI: 10.1016/j.eururo.2022.10.020
Waldbillig, Frank: An m6A-driven prognostic marker panel for renal cell carcinoma based on the first transcriptome-wide m6A-seq / Frank Waldbillig, Felix Bormann, Manuel Neuberger, Jörg Ellinger, Philipp Erben, Maximilian C. Krieg… , 21 February 2023. - 11 S.
In: Diagnostics, ISSN 2075-4418. 13(2023), 5, Artikel-ID 823, Seite 1-11
DOI: 10.3390/diagnostics13050823
Klümper, Niklas: C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma / Niklas Klümper, Danijel Sikic, Jonas Saal, Thomas Büttner, Franziska Goldschmidt, Jonas Jarczyk, Phi… , May 2022. - 10 S.
In: European journal of cancer, ISSN 1879-0852. 167(2022) vom: Mai, Seite 13-22
DOI: 10.1016/j.ejca.2022.02.022
Sikic, Danijel: High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer : laboratory-bladder cancer / Danijel Sikic, Markus Eckstein, Veronika Weyerer, Jennifer Kubon, Johannes Breyer, Florian Roghmann,… , February 2022. - 10 S.
In: Urologic oncology, ISSN 1873-2496. 40(2022), 2 vom: Feb., Seite 63.e9-63.e18
DOI: 10.1016/j.urolonc.2021.06.021
Neuberger, Manuel: Baseline modified Glasgow Prognostic Score (mGPS) predicts radiologic response and overall survival in metastatic hormone-sensitive prostate cancer treated with docetaxel chemotherapy / Manuel Neuberger, Janina Skladny, Nora Goly, Frederik Wessels, Christel Weiß, Luisa Egen, Philipp Er… , April 2022. - 8 S.
In: Anticancer research, ISSN 1791-7530. 42(2022), 4 vom: Apr., Seite 1911-1918
DOI: 10.21873/anticanres.15668
Mayr, Roman: Prognostic and predictive value of fibroblast growth factor receptor alterations in high-grade non-muscle-invasive bladder cancer treated with and without bacillus Calmette-Guérin immunotherapy : bladder cancer / Roman Mayr, Markus Eckstein, Ralph M. Wirtz, Ademi Santiago-Walker, Mahadi Baig, Ramesh Sundaram, Je… , June 2022. - 9 S.
In: European urology, ISSN 1873-7560. 81(2022), 6 vom: Juni, Seite 606-614
DOI: 10.1016/j.eururo.2022.02.028
Nientiedt, Malin: Upper tract urinary cancer recurrence after radical cystectomy : risk assessment of intraoperative frozen section / Malin Nientiedt, Frank Waldbillig, Felix Stroop, Philipp Nuhn, Philipp Erben, Zoran V. Popovic, Cleo… , February 4, 2022. - 9 S.
In: Urologia internationalis, ISSN 1423-0399. 106(2022), 8 vom: Aug., Seite 816-824
DOI: 10.1159/000521804
Mingardo, Enrico: A genome-wide association study with tissue transcriptomics identifies genetic drivers for classic bladder exstrophy / Enrico Mingardo, Glenda Beaman, Philip Grote, Agneta Nordenskjöld, William Newman, Adrian S. Woolf, … , 09 November 2022. - 11 S.
In: Communications biology, ISSN 2399-3642. 5(2022) vom: Nov., Artikel-ID 1203, Seite 1-11
DOI: 10.1038/s42003-022-04092-3
Sikic, Danijel: High androgen receptor mRNA expression is associated with improved outcome in patients with high-risk non-muscle-invasive bladder cancer / Danijel Sikic, Helge Taubert, Ralph M. Wirtz, Johannes Breyer, Markus Eckstein, Veronika Weyerer, Je… , 2021. - 12 S.
In: Life, ISSN 2075-1729. 11(2021), 7, Artikel-ID 642, Seite 1-12
DOI: 10.3390/life11070642
Jütte, Hendrik Jan: KRT20, KRT5, ESR1 and ERBB2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer / Hendrik Jütte, Moritz Reike, Ralph M. Wirtz, Maximilian Kriegmair, Philipp Erben, Karl Tully, Veroni… , 26 May 2021. - 13 S.
In: Journal of Personalized Medicine, ISSN 2075-4426. 11(2021), 6, Artikel-ID 473, Seite 1-13
DOI: 10.3390/jpm11060473
Weyerer, Veronika: Integration of spatial PD-L1 expression with the tumor immune microenvironment outperforms standard PD-L1 scoring in outcome prediction of urothelial cancer patients / Veronika Weyerer, Pamela L. Strissel, Reiner Strick, Danijel Sikic, Carol I. Geppert, Simone Bertz, … , 12 May 2021. - 15 S.
In: Cancers, ISSN 2072-6694. 13(2021), 10, Artikel-ID 2327, Seite 1-15
DOI: 10.3390/cancers13102327
Porubský, Štefan: The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma / Stefan Porubsky, Malin Nientiedt, Maximilian C. Kriegmair, Jörn-Helge Heinrich Siemoneit, Roger Sand… , 25 May 2021. - 11 S.
In: Scientific reports, ISSN 2045-2322. 11(2021) vom: 27. Mai, Artikel-ID 10926, Seite 1-11
DOI: 10.1038/s41598-021-90381-6
Herrmann, Jonas: RNA expression of DNA damage response genes in muscle-invasive bladder cancer : influence on outcome and response to adjuvant cisplatin-based chemotherapy / Jonas Herrmann, Helena Schmidt, Katja Nitschke, Cleo-Aron Weis, Philipp Nuhn, Jost von Hardenberg, M… , 18 April 2021. - 12 S.
In: International journal of molecular sciences, ISSN 1422-0067. 22(2021), 8, Artikel-ID 4188, Seite 1-12
DOI: 10.3390/ijms22084188
Uysal, Daniel: A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer / Daniel Uysal, Karl-Friedrich Kowalewski, Maximilian Christian Kriegmair, Ralph Wirtz, Zoran V. Popov… , March 12, 2021. - 19 S.
In: PLOS ONE, ISSN 1932-6203. 16(2021), 3, Artikel-ID e0248342, Seite 1-19
DOI: 10.1371/journal.pone.0248342
Förster, Sarah: Neuropilin-2 and its transcript variants correlate with clinical outcome in bladder cancer / Sarah Förster, Maryam Givehchi, Katja Nitschke, Thomas Mayr, Kerstin Kilian, Samikshan Dutta, Kaustu… , 9 April 2021. - 17 S.
In: Genes, ISSN 2073-4425. 12(2021), 4, Artikel-ID 550, Seite 1-17
DOI: 10.3390/genes12040550
Erben, Philipp: Molekulare Subtypen des Urothelkarzinoms der Harnblase : Hintergründe und klinische Relevanz / Philipp Erben, Christoph Becker, Igor Tsaur, Matthias B. Stope, Tilman Todenhöfer, Fachgruppe Moleku… , 2021. - 8 S.
In: Der Urologe. 60(2021), 1, Seite 81-88
DOI: 10.1007/s00120-020-01396-2
Nientiedt, Malin: B-MYB - p53-related relevant regulator for the progression of clear cell renal cell carcinoma / M. Nientiedt, K. Müller, K. Nitschke, P. Erben, A. Steidler, S. Porubsky, Z.V. Popovic, F. Waldbilli… , 2021. - 10 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 147(2021), 1, Seite 129-138
DOI: 10.1007/s00432-020-03392-7
Wahby, Sarah: POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer / Sarah Wahby, Jonas Jarczyk, Alexander Fierek, Jakob Heinkele, Cleo-Aron Weis, Markus Eckstein, Thoma… , 2021. - 8 S.
In: Translational oncology, ISSN 1936-5233. 14(2021), 1, Artikel-ID 100900, Seite 1-8
DOI: 10.1016/j.tranon.2020.100900
Wu, Sheng: Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration : prognostic implications for muscle invasive bladder cancer / Sheng Wu, Katja Nitschke, Thomas Stefan Worst, Alexander Fierek, Cleo-Aron Weis, Markus Eckstein, St… , 17 December 2020. - 16 S.
In: Journal of experimental & clinical cancer research, ISSN 1756-9966. 39(2020), Artikel-ID 288, Seite 1-16
DOI: 10.1186/s13046-020-01795-5
Rinaldetti, Sébastien: Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer / Sebastien Rinaldetti, Thomas Stefan Worst, Eugen Rempel, Maximilian C. Kriegmair, Arndt Hartmann, St… , 24 November 2020. - 9 S.
In: Scientific reports, ISSN 2045-2322. 10(2020) Artikel-Nummer 20472, 9 Seiten
DOI: 10.1038/s41598-020-77252-2
Wessels, Frederik: Radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid / F. Wessels, M.C. Kriegmair, A. Oehme, M.C. Rassweiler-Seyfried, P. Erben, R. Oberneder, M. Kriegmair… , 22 February 2019. - 6 S.
In: European journal of surgical oncology, ISSN 1532-2157. 45(2019), 7, Seite 1260-1265
DOI: 10.1016/j.ejso.2019.02.023
Wu, Sheng: ANLN and TLE2 in muscle invasive bladder cancer : a functional and clinical evaluation based on in silico and in vitro data / Sheng Wu, Katja Nitschke, Jakob Heinkele, Cleo-Aron Weis, Thomas Stefan Worst, Markus Eckstein, Stef… , 21 November 2019. - 16 S.
In: Cancers, ISSN 2072-6694. 11(2019,12) Artikel-Nummer 1840, 16 Seiten
DOI: 10.3390/cancers11121840
Sikic, Danijel: Androgen receptor mRNA expression in urothelial carcinoma of the bladder : a retrospective analysis of two independent cohorts / Danijel Sikic, Ralph M. Wirtz, Sven Wach, Lars Dyrskjøt, Philipp Erben, Christian Bolenz, Johannes B… , April 2019. - 8 S.
In: Translational oncology, ISSN 1936-5233. 12(2019), 4, Seite 661-668
DOI: 10.1016/j.tranon.2019.01.005
Kriegmair, Maximilian: Prognostic value of molecular breast cancer subtypes based on Her2, ESR1, PGR and Ki67 mRNA-expression in muscle invasive bladder cancer / M.C. Kriegmair, R.M. Wirtz, T.S. Worst, J. Breyer, M. Ritter, B. Keck, C. Boehmer, W. Otto, M. Eckst… , April 2018. - 10 S.
In: Translational oncology, ISSN 1936-5233. 11(2018), 2, Seite 467-476
DOI: 10.1016/j.tranon.2018.02.001
Wezel, Felix: Complete and durable remission of human epidermal growth factor receptor 2-positive metastatic urothelial carcinoma following third-line treatment with trastuzumab and gemcitabine / Felix Wezel, Philipp Erben, Timo Gaiser, Johannes Budjan, Jost von Hardenberg, Maurice Stephan Miche… , January 2018. - 4 S.
In: Urologia internationalis, ISSN 1423-0399. 100(2018), 1, Seite 122-125
DOI: 10.1159/000443280
Bolenz, Christian: Decreased invasion of urothelial carcinoma of the bladder by inhibition of matrix-metalloproteinase 7 / Christian Bolenz, Daniel Knauf, Axel John, Philipp Erben, Annette Steidler, Stefan W. Schneider, Cag… , 20 January 2018. - 9 S.
In: Bladder cancer, ISSN 2352-3735. 4(2018), 1, Seite 67-75
DOI: 10.3233/BLC-170124
Rinaldetti, Sébastien: FOXM1 predicts disease progression in non-muscle invasive bladder cancer / Sebastien Rinaldetti, Ralph Wirtz, Thomas Stefan Worst, Arndt Hartmann, Johannes Breyer, Lars Dyrskj… , 29 June 2018. - 9 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 144(2018), 9, Seite 1701-1709
DOI: 10.1007/s00432-018-2694-5
Rinaldetti, Sébastien: Subclassification, survival prediction and drug target analyses of chemotherapy-nai͏̈ve muscle-invasive bladder cancer with a molecular screening / Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, Markus Eckstein, Annette Steidler, Cleo Aar… , May 25, 2018. - 11 S.
In: OncoTarget, ISSN 1949-2553. 9(2018), 40, Seite 25935-25945
DOI: 10.18632/oncotarget.25407
Martini, Thomas: Erratum to "Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy" : [urologic oncology seminars and original investigations 36/12 (2018) 505-534] / Thomas Martini, Jakob Heinkele, Roman Mayr, Cleo-Aron Weis, Felix Wezel, Sarah Wahby, Markus Eckstei… , 2019. - 1 S.
In: Urologic oncology, ISSN 1873-2496. 37(2019), 3, Seite 227
DOI: 10.1016/j.urolonc.2018.12.019
Martini, Thomas: Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy / Thomas Martini, Jakob Heinkele, Roman Mayr, Cleo-Aron Weis, Felix Wezel, Sarah Wahby, Markus Eckstei… , [December 2018]. - 9 S.
In: Urologic oncology, ISSN 1873-2496. 36(2018), 12, Seite 530.e19-530.e27
DOI: 10.1016/j.urolonc.2018.09.003
Breyer, Johannes: FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer / Johannes Breyer, Ralph M. Wirtz, Philipp Erben, Sebastien Rinaldetti, Thomas S. Worst, Robert Stoehr… , 2019. - 10 S.
In: BJU international, ISSN 1464-410X. 123(2019), 1, Seite 187-196
DOI: 10.1111/bju.14525
Breyer, Johannes: High CDKN2A/p16 and low FGFR3 expression predict progressive potential of stage pT1 urothelial bladder carcinoma / Johannes Breyer, Ralph M. Wirtz, Philipp Erben, Thomas S. Worst, Robert Stoehr, Markus Eckstein, Sim… , Feb 2, 2018. - 11 S.
In: Clinical genitourinary cancer, ISSN 1938-0682. 16(2018), 4, Seite 248-256.e2
DOI: 10.1016/j.clgc.2018.01.009
Eckstein, Markus: A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy / Markus Eckstein, Ralph M. Wirtz, Carolin Pfannstil, Sven Wach, Robert Stoehr, Johannes Breyer, Franz… , March 13, 2018. - 14 S.
In: OncoTarget, ISSN 1949-2553. 9(2018), 19, Seite 15001-15014
DOI: 10.18632/oncotarget.24531
Eckstein, Markus: Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab / Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair, Thomas S. Worst, Cleo-Aron Weiß, Ralph M. W… , 2019. - 10 S.
In: European journal of cancer, ISSN 1879-0852. 106(2019), Seite 234-243
DOI: 10.1016/j.ejca.2018.11.007
Erben, Philipp: Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder / Philipp Erben, Danijel Sikic, Ralph M. Wirtz, Thomas Martini, Cleo-Aron Weis, Johannes Breyer, Wolfg… , 2019. - 9 S.
In: Virchows Archiv, ISSN 1432-2307. 474(2019), 2, Seite 209-217
DOI: 10.1007/s00428-018-2496-9
Hardenberg, Jost von: Cell-free DNA and neuromediators in detecting aggressive variant prostate cancer / Jost von Hardenberg, Thomas S. Worst, Niklas Westhoff, Philipp Erben, Stefan Fuxius, Markus Müller, … , September 10, 2018. - 7 S.
In: Oncology research and treatment, ISSN 2296-5262. 41(2018), 10, Seite 627-633
DOI: 10.1159/000490618
Hardenberg, Jost von: Programmed death ligand 1 (PD-L1) status and tumor-infiltrating lymphocytes in hot spots of primary and liver metastases in prostate cancer with neuroendocrine differentiation / Jost von Hardenberg, Sarah Hartmann, Katja Nitschke, Thomas Stefan Worst, Saskia Ting, Henning Reis,… , 2019. - 14 S.
In: Clinical genitourinary cancer, ISSN 1938-0682. 17(2019), 2, Seite 145-153.e5
DOI: 10.1016/j.clgc.2018.12.007
Eckstein, Markus: mRNA-expression of KRT5 and KRT20 defines distinct prognostic subgroups of muscle-invasive urothelial bladder cancer correlating with histological variants / Markus Eckstein, Ralph Markus Wirtz, Matthias Gross-Weege, Johannes Breyer, Wolfgang Otto, Robert St… , 30 October 2018. - 14 S.
In: International journal of molecular sciences, ISSN 1422-0067. 19(2018), 11, Artikel-ID 3396, Seite 1-14
DOI: 10.3390/ijms19113396
Worst, Thomas: CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making / Thomas S. Worst, Cleo-Aron Weis, Robert Stöhr, Simone Bertz, Markus Eckstein, Wolfgang Otto, Johanne… , 26 September 2018
In: Scientific reports, ISSN 2045-2322. 8(2018) Artikel-Nummer 14383, 10 Seiten
DOI: 10.1038/s41598-018-32569-x
Worst, Thomas: Database-augmented mass spectrometry analysis of exosomes identifies claudin 3 as a putative prostate cancer biomarker / Thomas Stefan Worst, Jost von Hardenberg, Julia Christina Gross, Philipp Erben, Martina Schnölzer, I… , April 9, 2017. - 11 S.
In: Molecular & cellular proteomics, ISSN 1535-9484. 16(2017), 6, Seite 998-1008
DOI: 10.1074/mcp.M117.068577
Worst, Thomas: RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cells / Thomas Stefan Worst, Yannic Meyer, Maria Gottschalt, Cleo-Aron Weis, Jost von Hardenberg, Christine … , February 10, 2017. - 13 S.
In: International journal of oncology, ISSN 1791-2423. 50(2017), 3, Seite 920-932
DOI: 10.3892/ijo.2017.3872
Worst, Thomas: Novel insights into a reputably irreversible process : combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy / T.S. Worst, K. Daskalova, A. Steidler, K. Berner-Leischner, R. Röth, B. Niesler, C.-A. Weis, M.C. Kr… , 20 June 2017. - 11 S.
In: World journal of urology, ISSN 1433-8726. 35(2017), 11, Seite 1701-1711
DOI: 10.1007/s00345-017-2060-2
Sikic, Danijel: High androgen receptor mRNA expression is independently associated with prolonged cancer-specific and recurrence-free survival in stage T1 bladder cancer / Danijel Sikic, Johannes Breyer, Arndt Hartmann, Maximilian Burger, Philipp Erben, Stefan Denzinger, … , 2017. - 6 S.
In: Translational oncology, ISSN 1936-5233. 10(2017), 3, Seite 340-345
DOI: 10.1016/j.tranon.2017.01.013
Breyer, Johannes: High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients / Johannes Breyer, Ralph M. Wirtz, Wolfgang Otto, Philipp Erben, Thomas S. Worst, Robert Stoehr, Marku… , 2018. - 10 S.
In: Cancer immunology immunotherapy, ISSN 1432-0851. 67(2018), 3, Seite 403-412
DOI: 10.1007/s00262-017-2093-9
Breyer, Johannes: In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival / Johannes Breyer, Ralph M. Wirtz, Wolfgang Otto, Philipp Erben, Maximilian C. Kriegmair, Robert Stoeh… , 10 January 2017. - 8 S.
In: Virchows Archiv, ISSN 1432-2307. 470(2017), 3, Seite 267-274
DOI: 10.1007/s00428-017-2064-8
Erben, Philipp: Bedeutung der ERBB-Rezeptorfamilie beim Urothelkarzinom der Harnblase : mRNA-Expression und prognostische Relevanz / Philipp Erben, Felix Wezel, Ralph Wirtz, Thomas Martini, Doron Stein, Cleo-Aaron Weis, Arndt Hartman… , 27.Juli 2017. - 7 S.
In: Aktuelle Urologie, ISSN 1438-8820. 48(2017), 4, Seite 356-362
DOI: 10.1055/s-0043-110403
Breyer, Johannes: Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies / Johannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, Mark Laible, Kornelia Schlombs, Philipp Erben, M… , 2017. - 12 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 40, Seite 67684-67695
DOI: 10.18632/oncotarget.18804
Rinaldetti, Sébastien: FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes / Sebastien Rinaldetti, Ralph Markus Wirtz, Thomas Stefan Worst, Markus Eckstein, Cleo Aaron Weiss, Jo… , April 24, 2017. - 12 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 29, Seite 47595-47606
DOI: 10.18632/oncotarget.17394
Worst, Thomas: Impact of altered WNT2B expression on bladder wall fibroblasts : implications for apoptosis regulation in the stroma of the lower urinary tract / Thomas Stefan Worst, Kristina Daskalova, Annette Steidler, Karin Berner-Leischner, Ralph Röth, Beate… , December 2017. - 8 S.
In: Urologia internationalis, ISSN 1423-0399. 99(2017), 4, Seite 476-483
DOI: 10.1159/000481440
Breyer, Johannes: ERBB2 expression as potential risk-stratification for early cystectomy in patients with pT1 bladder cancer and concomitant carcinoma in situ / Johannes Breyer, Wolfgang Otto, Ralph M. Wirtz, Bernd Wullich, Bastian Keck, Philipp Erben, Maximili… , April 2017. - 8 S.
In: Urologia internationalis, ISSN 1423-0399. 98(2017), 3, Seite 282-289
DOI: 10.1159/000453670
Worst, Thomas: The EEF1A2 gene expression as risk predictor in localized prostate cancer / Thomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, Cleo-Aron Weis, Maria Gottschalt, Annette… , 18 September 2017
In: BMC urology, ISSN 1471-2490. 17(2017) Artikel-Nummer 86, 9 Seiten
DOI: 10.1186/s12894-017-0278-3
Worst, Thomas: The EEF1A2 gene expression as risk predictor in localized prostate cancer / Thomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, Cleo-Aron Weis, Maria Gottschalt, Annette… . -
London: BioMed Central, 18 September 2017. - 1 Online-Ressource (9 Seiten)
DOI: 10.1186/s12894-017-0278-3
Breyer, Johannes: ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC) / Johannes Breyer, Ralph M. Wirtz, Mark Laible, Kornelia Schlombs, Philipp Erben, Maximilian Christian… , 11 August 2016. - 6 S.
In: Virchows Archiv, ISSN 1432-2307. 469(2016), 5, Seite 547-552
DOI: 10.1007/s00428-016-2002-1
Kriegmair, Maximilian: Expression of the p53 inhibitors MDM2 and MDM4 as outcome predictor in muscle-invasive bladder cancer / Maximilian Christian Kriegmair, Matthias Balk, Ralph Wirtz, Annette Steidler, Cleo-Aron Weis, Johann… , October 2016. - 9 S.
In: Anticancer research, ISSN 1791-7530. 36(2016), 10, Seite 5205-5213
Umbreit, Claudia: Lapatinib‑induced mesenchymal‑epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β‑catenin expression / Claudia Umbreit, Philipp Erben, Anne Faber, Ralf-Dieter Hofheinz, Johannes David Schultz, Karl Hoerm… , March 1, 2016. - 10 S.
In: Oncology letters, ISSN 1792-1082. 11(2016), 4, Seite 2715-2724
DOI: 10.3892/ol.2016.4293
Kripp, Melanie: Prognostic impact of mRNA expression levels of HER1-4 (ERBB1-4) in patients with locally advanced rectal cancer / Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, Timo Gaiser, Sebastian Eidt, Juliana Schwaab, Stefa… , 2016. - 9 S.
In: Gastroenterology research and practice, ISSN 1687-630X. (2016) Artikel-Nummer 3481578, 9 Seiten
DOI: 10.1155/2016/3481578
Umbreit, Claudia: MMP9, Cyclin D1 and β-Catenin are useful markers of p16-positive squamous cell carcinoma in therapeutic EGFR inhibition in vitro / Claudia Umbreit, Philipp Erben, Anne Faber, Ralf-Dieter Hofheinz, Christoph Aderhold, Christel Weiss… , July 2015. - 10 S.
In: Anticancer research, ISSN 1791-7530. 35(2015), 7, Seite 3801-3810
Erben, Philipp: Molekulare Charakterisierung des Urothelkarzinoms der Harnblase : Ist ein klinischer Nutzen in Sicht? / P. Erben, A. Hartmann, C. Bolenz, 2015. - 9 S.
In: Aktuelle Urologie, ISSN 1438-8820. 46(2015), 3, Seite 227-235
DOI: 10.1055/s-0035-1549992
Martini, Thomas: Detektion der lymphovaskulären Invasion mit D2-40-Immunhistochemie beim Urothelkarzinom der Harnblase / T. Martini, P. Ströbel, A. Steidler, N. Petrakopoulou, P. Erben, C. Bolenz, 2015. - 6 S.
In: Der Urologe. 54(2015), 1, Seite 70-75
DOI: 10.1007/s00120-014-3646-6
Schmitt-Graeff, Annette: The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophilia / Annette Hildegard Schmitt-Graeff, Philipp Erben, Juliane Schwaab, Beate Vollmer-Kary, Georgia Metzge… , January 2014. - 3 S.
In: Blood, ISSN 1528-0020. 123(2014), 4, Seite 595-597
DOI: 10.1182/blood-2013-10-530642
Erben, Philipp: The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis / Philipp Erben, Juliana Schwaab, Georgia Metzgeroth, Hans-Peter Horny, Mohamad Jawhar, Karl Sotlar, A… , 2014. - 8 S.
In: Annals of hematology, ISSN 1432-0584. 93(2014), 1, Seite 81-88
DOI: 10.1007/s00277-013-1964-1
Philipp, Martin Bernd: Expression of transketolase‑like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML) / M. Philipp, J. Schwaab, C.T. Dietz, B. Hanfstein, L. Kalmanti, U. Munjal, M. Mossner, Nowak W. Seifa… , March 2014. - 7 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 3, Seite 411-417
DOI: 10.1007/s00432-013-1579-x
Gosenca, Darko: Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms / Darko Gosenca, Beate Kellert, Georgia Metzgeroth, Claudia Haferlach, Alice Fabarius, Juliana Schwaab… , May 2014. - 11 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 53(2014), 5, Seite 411-421
DOI: 10.1002/gcc.22153
Agrawal, Mridul: MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure / Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha,… , 2014. - 8 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 7, Seite 1478-1485
DOI: 10.1038/leu.2014.6
Heinzelbecker, Julia: Microvascular invasion of testicular nonseminomatous germ cell tumors : implications of separate evaluation of lymphatic and blood vessels / Heinzelbecker, Julia; Gross-Weege, Matthias; Weiss, Christel; Hoerner, Christian; Trunk, Marcus J.; … , 2014. - 7 S.
In: The journal of urology, ISSN 1527-3792. 192(2014), 2, Seite 593-599
DOI: 10.1016/j.juro.2014.02.2569
Hanfstein, Benjamin: Comparing the prognostic significance of early predictors of survival in chronic myeloid leukemia (CML) treated with imatinib : an analysis of the randomized CML-study IV / Benjamin Hanfstein, Michael Lauseker, Rüdiger Hehlmann, Susanne Saussele, Philipp Erben, Christian D… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 70540, 1 S.
Hanfstein, Benjamin: A two-fold rise of BCR-ABL transcript levels advises BCR-ABL mutation analysis in imatinib-treated chronic myeloid leukemia (CML) : an analysis of the randomized CML-study IV / Benjamin Hanfstein, Niklas Westhoff, Rüdiger Hehlmann, Susanne Saussele, Michael Lauseker, Thomas Er… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 3138, 1 S.
Hanfstein, Benjamin: Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib / Hanfstein, Benjamin ... Hehlmann, Ruediger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fab… , 2014. - 7 S.
In: Haematologica, ISSN 1592-8721. 99d(2014), 9, Seite 1441-1447
DOI: 10.3324/haematol.2013.096537
Hanfstein, Benjamin: Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib / Hanfstein, B.; Shlyakhto, V. ... Hehlmann, R.; Saussele, S.; Dietz, C.; Erben, P.; Fabarius, A.; Pro… , 2014. - 5 S.
In: Leukemia, ISSN 1476-5551. 28(2014), 10, Seite 1988-1992
DOI: 10.1038/leu.2014.153
Lauseker, Michael: Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase / Lauseker, Michael; Hanfstein, Benjamin ... Fabarius, Alice ... Saussele, Susanne; Dietz, Christian T… , 2014. - 5 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 11, Seite 1965-1969
DOI: 10.1007/s00432-014-1746-8
Umbreit, Claudia: Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with beta-catenin expression / Umbreit, Claudia; Flanjak, Julia; Weiss, Christel; Erben, Philipp; Aderhold, Christoph; Faber, Anne;… , 2014. - 9 S.
In: Anticancer research, ISSN 0250-7005. 34(2014), 12, Seite 7061-7069
Erben, Philipp: Evaluation prädiktiver molekularer Marker für die neoadjuvante Radiochemotherapie des lokal fortgeschrittenen Rektumkarzinoms / vorgelegt von Philipp Franz Wilhelm Erben, 2013 [ersch.] 2014. - 111 Bl. : graph. Darst.
Lengfelder, Eva: Outcome of elderly patients with acute promyelocytic leukemia : results of the German Acute Myeloid Leukemia Cooperative Group / Lengfelder, Eva; Hanfstein, Benjamin ... Erben, Philipp ... Hehlmann, Ruediger; Hofmann, Wolf-Karste… , 2013. - 12 S.
In: Annals of hematology, ISSN 1432-0584. 92(2013), 1, Seite 41-52
DOI: 10.1007/s00277-012-1597-9
Schwaab, Juliana: Comprehensive mutational profiling in advanced systemic mastocytosis / Schwaab, Juliana ... Fabarius, Alice ... Jawhar, Mohamad ... Metzgeroth, Georgia; Erben, Philipp ...… , 2013. - 7 S.
In: Blood, ISSN 1528-0020. 122(2013), 14, Seite 2460-2466
DOI: 10.1182/blood-2013-04-496448
Hochhaus, Andreas: Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia : analysis of the phase 2, open-label, single-arm A2101 study / Hochhaus, Andreas ... Erben, Philipp; Reiter, Andreas ..., 2013. - 9 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 139(2013), 12, Seite 1985-1993
DOI: 10.1007/s00432-013-1529-7
La Rosée, Paul: Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib / La Rosee, Paul ... Mueller, Martin C.; Erben, Philipp ... Saussele, Susanne ..., 2013. - 6 S.
In: Annals of hematology, ISSN 0939-5555. 92(2013), 10, Seite 1345-1350
Aderhold, Marc Christoph: Chemotherapeutic alteration of VEGF, PDGF and PDGFR alpha/beta expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro / Aderhold, Christoph; Umbreit, Claudia; Faber, Anne; Sauter, Alexander; Sommer, Joerg Ulrich; Birk, R… , 2013. - 11 S.
In: Anticancer research, ISSN 0250-7005. 33(2013), 5, Seite 1951-1961
Merx, Kirsten: Effects of imatinib mesylate in patients with polycythemia vera : results of a phase II study / Merx, Kirsten; Fabarius, Alice; Erben, Philipp ... Reiter, Andreas; Hofmann, Wolf-Karsten; Hehlmann,… , 2013. - 9 S.
In: Annals of hematology, ISSN 0939-5555. 92(2013), 7, Seite 907-915
Klag, Thomas-Matthias: Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro : potential role of the common β-subunit c of cytokine receptors / T. Klag, N. Härtel, P. Erben, J. Schwaab, U. Schnetzke, T. Schenk, A. Hochhaus, P. La Rosée, 13 January 2012. - 8 S.
In: Leukemia, ISSN 1476-5551. 26(2012), 6, Seite 1321-1328
DOI: 10.1038/leu.2011.380
Erben, Philipp: Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions / Philipp Erben, Daniel Nowak, Christian Sauer, Philipp Ströbel, Wolf-Karsten Hofmann, Ralf-Dieter Hof… , October 22, 2012. - 5 S.
In: Onkologie, ISSN 1423-0240. 35(2012), 11, Seite 684-688
DOI: 10.1159/000343744
Metzgeroth, Georgia: Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation / G. Metzgeroth, P. Erben, H. Martin, S. Mousset, M. Teichmann, C. Walz, T. Klippstein, A. Hochhaus, N… , January 2012. - 3 S.
In: Leukemia, ISSN 1476-5551. 26(2012), 1, Seite 162-164
DOI: 10.1038/leu.2011.181
Lammert, Anne: Alteration of MMP-2 and -14 expression by imatinib in HPV-positive and -negative squamous cell carcinoma / Anne Faber, Alexander Sauter, Sarah Hoedt, Karl Hoermann, Philipp Erben, Ralf-Dieter Hofheinz, Ulric… , April 20, 2012. - 7 S.
In: Oncology reports, ISSN 1791-2431. 28(2012), 1, Seite 172-178
DOI: 10.3892/or.2012.1766
Nowak, Daniel: SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3 / Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, Maximilian Mossner, Florian Nolte, Verena Nowa… , 9 April 2012. - 12 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 51(2012), 8, Seite 756-767
DOI: 10.1002/gcc.21961
Hanfstein, Benjamin: Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) / B Hanfstein, MCMü̈ller, R Hehlmann, P Erben, M Lauseker, A Fabarius, S Schnittger, C Haferlach, G Gö… , 24 April 2012. - 7 S.
In: Leukemia, ISSN 1476-5551. 26(2012), 9, Seite 2096-2102
DOI: 10.1038/leu.2012.85
Schwaab, Juliana: Activating CBL mutations are associated with a distinct MDS/MPN phenotype / Juliana Schwaab, Thomas Ernst, Philipp Erben, Jenny Rinke, Susanne Schnittger, Philipp Ströbel, Geor… , 10 August 2012. - 8 S.
In: Annals of hematology, ISSN 1432-0584. 91(2012), 11, Seite 1713-1720
DOI: 10.1007/s00277-012-1521-3
Schultz, Johannes D.: Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro / J.D. Schultz, J.U. Sommer, S. Hoedt, P. Erben, R.D. Hofheinz, A. Faber, C. Thorn, K. Hörmann and A. … , 2012. - 11 S.
In: Oncology reports, ISSN 1791-2431. 27(2012), 1, Seite 270-280
DOI: 10.3892/or.2011.1499
Gosenca, Darko: HERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinoma / Darko Gosenca, Ute Gabriel, Annette Steidler, Jens Mayer, Olivia Diem, Philipp Erben, Alice Fabarius… , November 7, 2012. - 15 S.
In: PLOS ONE, ISSN 1932-6203. 7(2012,11) Artikel-Nummer 0049341, 15 Seiten
DOI: 10.1371/journal.pone.0049341
Erben, Philipp: Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions / Philipp Erben; Daniel Nowak; Christian Sauer; Philipp Ströbel; Wolf-Karsten Hofmann; Ralf-Dieter Hof… . -
Basel: S. Karger, 2012. - Online-Ressource (6 S.)
Erben, Philipp: Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions / Erben, Philipp; Nowak, Daniel; Sauer, Christian; Stroebel, Philipp; Hofmann, Wolf-Karsten; Hofheinz,… , 2012. - 5 S.
In: Onkologie, ISSN 0378-584X. 35(2012), 11, Seite 684-688
Schwaab, Juliana: Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy / Juliana Schwaab, Karoline Horisberger, Philipp Ströbel, Beatrice Bohn, Deniz Gencer, Georg Kähler, P… , 19 August 2011. - 9 S. : Diagramme
In: BMC cancer, ISSN 1471-2407. 11(2011) vom: Aug., Artikel-ID 363, Seite 1-9
DOI: 10.1186/1471-2407-11-363
Schultz, Johannes D.: Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro / J.D. Schultz, S. Rotunno, F. Riedel, C. Anders, P. Erben, R.D. Hofheinz, A. Faber, C. Thorn, J.U. So… , January 18, 2011. - 12 S. : Illustrationen
In: International journal of oncology, ISSN 1791-2423. 38(2011), 4 vom: Jan., Seite 1001-1012
DOI: 10.3892/ijo.2011.912
Schultz, Johannes D.: Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC / Johannes D. Schultz, Sarah Rotunno, Philipp Erben, J. Ulrich Sommer, Clemens Anders, Jens Stern-Stra… , January 18, 2011. - 7 S. : Illustrationen
In: Oncology reports, ISSN 1791-2431. 25(2011), 4, Seite 1145-1151
DOI: 10.3892/or.2011.1153
Schultz, Johannes D.: Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro / J.D. Schultz, K. Mühlheim, P. Erben, R.D. Hofheinz, A. Faber, C. Thorn, J.U. Sommer, K. Hörmann and … , July 26, 2011. - 11 S. : Illustrationen
In: Oncology reports, ISSN 1791-2431. 26(2011), 5, Seite 1099-1109
DOI: 10.3892/or.2011.1403
Härtel, Nicolai: Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells : a potential mechanism of altered leukemogenicity / Nicolai Härtel, Thomas Klag, Benjamin Hanfstein, Martin C. Mueller, Thomas Schenk, Philipp Erben, An… , 2012. - 10 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 138(2012), 2, Seite 203-212
DOI: 10.1007/s00432-011-1086-x
Erben, Philipp: Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis / Philipp Erben, Darko Gosenca, Martin C. Müller, Jelena Reinhard, Joannah Score, Francesco del Valle,… , 2010-05-01. - 7 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 5 vom: Mai, Seite 738-744
DOI: 10.3324/haematol.2009.016345
Horisberger, Karoline: Annexin and Survivin in locally advanced rectal cancer : indicators of resistance to preoperative chemoradiotherapy? / Karoline Horisberger, Philipp Erben, Philipp Ströbel, Beatrice Bohn, Melanie Hahn, Georg Kähler, Fre… , September 2010. - 6 S. : 1 Diagramm
In: Onkologie, ISSN 1423-0240. 33(2010), 8/9 vom: Sept., Seite 439-444
DOI: 10.1159/000318145
Chase, Andrew: TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals / Andrew Chase, Thomas Ernst, Andreas Fiebig, Andrew Collins, Francis Grand, Philipp Erben, Andreas Re… , January 1, 2010. - 7 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 1, Seite 20-26
DOI: 10.3324/haematol.2009.011536
Krämer, Alwin: JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia / Alwin Krämer, Andreas Reiter, Jens Kruth, Philipp Erben, Andreas Hochhaus, Martin Müller, Nicholas C… , [July 2007]. - 3 S. : Diagramme
In: The lancet, ISSN 1474-5488. 8(2007), 7, Seite 658-660
DOI: 10.1016/S1470-2045(07)70206-1
Walz, Christoph: Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene / Christoph Walz, Claire Curtis, Susanne Schnittger, Beate Schultheis, Georgia Metzgeroth, Claudia Sch… , 14 July 2006. - 7 S.
In: Genes, chromosomes & cancer, ISSN 1098-2264. 45(2006), 10, Seite 950-956
DOI: 10.1002/gcc.20359
Michel, Maurice Stephan: Acoustic energy : a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cells / Maurice Stephan Michel, Philipp Erben, Lutz Trojan, Axel Schaaf, Koba Kiknavelidze, Thomas Knoll and… , July 1, 2004. - 6 S.
In: Anticancer research, ISSN 1791-7530. 24(2004), 4, Seite 2303-2308
Michel, Maurice Stephan: Prostate cancer transfection by acoustic energy using pEGFP-N1 as reporter gene in the solid Dunning R-3327-MatLu tumor / MS Michel, P Erben, L Trojan, T Knoll & P Alken, 09 December 2003. - 4 S.
In: Prostate cancer and prostatic diseases, ISSN 1476-5608. 6(2003), 4, Seite 290-293
DOI: 10.1038/sj.pcan.4500667
Erben, Philipp: Akustische Energie zur Transfektion beim Prostatakarzinom : Entwicklung und Evaluation / vorgelegt von Philipp Franz Wilhelm Erben, 2003. - IX, 94 Bl. : Ill., graph. Darst.

IDs

GND:

128501014

Links

Erben, Philipp in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design